This study is testing a product called NeoThelium FT (HCT/P 361) to see how well it works and if it's safe for people with diabetic foot ulcers. NeoThelium FT is a wound covering made from donated human placental tissue. The study is looking for about 10 adults, aged 18 or older, who have type 1 or type 2 diabetes and a diabetic foot ulcer that isn't infected and doesn't have exposed bone. The main goal is to see if the ulcers completely close within 1 to 12 weeks. The study's current status is unclear, so we don't know if they are actively recruiting participants right now.

Study design

This is a case series study where both you and the researchers will know which treatment you are receiving (open-label). About 10 participants are planned for this study.

What's involved

If you join, you will receive weekly applications of NeoThelium FT in addition to standard care. You will continue to have follow-up appointments according to the original schedule.

Compensation

Not stated in the trial record.

Follow-up

The study will follow your wound closure for 1 to 12 weeks.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.